192 related articles for article (PubMed ID: 11884211)
1. A novel concept to preserve the beneficial effects of hormone replacement therapy in bilaterally female ovariectomized rats: role of lovastatin therapy.
El-Swefy SE; Asker ME; Ali SI; Mohammed HE
Pharmacol Res; 2002 Mar; 45(3):167-73. PubMed ID: 11884211
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: role of folic acid and hormone replacement therapy.
el-Swefy SE; Ali SI; Asker ME; Mohamed HE
J Pharm Pharmacol; 2002 Mar; 54(3):391-7. PubMed ID: 11902805
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
[TBL] [Abstract][Full Text] [Related]
4. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats.
Shehata M; Kamel MA
Endocr Regul; 2008 Jun; 42(2-3):69-75. PubMed ID: 18624609
[TBL] [Abstract][Full Text] [Related]
6. Management of hypercholesterolaemia in postmenopausal women.
Davidson MH; Maki KC; Karp SK; Ingram KA
Drugs Aging; 2002; 19(3):169-78. PubMed ID: 12027776
[TBL] [Abstract][Full Text] [Related]
7. Effect of a HMG-CoA reductase inhibitor combined with hormone replacement therapy on lipid metabolism in Japanese women with hypoestrogenic lipidemia: a multicenter double-blind controlled prospective study.
Ohta H; Komukai S; Sugimoto I; Fuyuki T; Makita K; Takamatsu K; Horiguchi F; Nozawa S
Maturitas; 1998 Jun; 29(2):163-71. PubMed ID: 9651906
[TBL] [Abstract][Full Text] [Related]
8. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
[TBL] [Abstract][Full Text] [Related]
9. The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women.
Seed M
Atheroscler Suppl; 2002 May; 3(1):53-63. PubMed ID: 12044587
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C.
Hamilton VH; Racicot FE; Zowall H; Coupal L; Grover SA
JAMA; 1995 Apr; 273(13):1032-8. PubMed ID: 7897787
[TBL] [Abstract][Full Text] [Related]
11. Nicotine and vascular endothelial dysfunction in female ovariectomized rats: role of estrogen replacement therapy.
El-Seweidy MM; Mohamed HE; Asker ME; Atteia HH
J Pharm Pharmacol; 2012 Jan; 64(1):108-19. PubMed ID: 22150678
[TBL] [Abstract][Full Text] [Related]
12. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
[TBL] [Abstract][Full Text] [Related]
13. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.
Ridker PM; Rifai N; Clearfield M; Downs JR; Weis SE; Miles JS; Gotto AM;
N Engl J Med; 2001 Jun; 344(26):1959-65. PubMed ID: 11430324
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
Skouby SO; Gram J; Andersen LF; Sidelmann J; Petersen KR; Jespersen J
Am J Obstet Gynecol; 2002 May; 186(5):969-77. PubMed ID: 12015523
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
Darling GM; Johns JA; McCloud PI; Davis SR
N Engl J Med; 1997 Aug; 337(9):595-601. PubMed ID: 9271481
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term estrogen replacement therapy versus combined hormone replacement therapy on nitric oxide-dependent vasomotor function.
Jokela H; Dastidar P; Rontu R; Salomäki A; Teisala K; Lehtimäki T; Punnonen R
J Clin Endocrinol Metab; 2003 Sep; 88(9):4348-54. PubMed ID: 12970309
[TBL] [Abstract][Full Text] [Related]
17. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
18. Effect of ovariectomy and replacement therapy on the tissue lipid pattern in rats.
Mukherjea M; Biswas R
Endokrinologie; 1975 Nov; 66(2):113-21. PubMed ID: 1227843
[TBL] [Abstract][Full Text] [Related]
19. [Effect of hormone replacement therapy on blood serum lipids in postmenopausal women with type 2 diabetes].
Kozlov SG; Dotsenko IuV; Sankova AV; Liakishev AA; Tvorogova MG; Afanas'eva OI; Titov VN; Pokrovskiĭ SN; Naumov VG
Kardiologiia; 2002; 42(7):47-52. PubMed ID: 12494113
[TBL] [Abstract][Full Text] [Related]
20. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
